CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Kensey Nash Corporation is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Kensey Nash Corporation
735 Pennsylvania Drive
Phone: (484) 713-2100p:484 713-2100 Exton, PA  19341  United States Fax: (484) 713-2900f:484 713-2900

This company ceased filing statements with the SEC on 7/2/2012.
As of 5/3/2023, the Company is part of Koninklijke DSM NV, a subsidiary of DSM-Firmenich AG
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company

Business Summary
Kensey Nash Corporation is a medical device company primarily focused in the field of regenerative medicine, which is the application of devices, materials and other therapies to help repair damaged or diseased tissues. The Company has a range of products, which are sold through strategic partners in multiple large medical markets, including cardiology, orthopaedic, sports medicine, spinal and general surgery. It also has an ongoing development and manufacturing program for products in the endovascular market. During the fiscal year ended June 30, 2010 (fiscal 2010), the Company manufactured and sold over 4.5 million resorbable product units representing approximately 230 commercialized products, to strategic partners and customers. In January 2011, the Company acquired Nerites Corporation. In June 2012, Koninklijke DSM NV acquired the Company.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/20126/30/2011YesYes--Yes

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Walter R.Maupay 72 9/1/2005 6/1/1995
President, Chief Executive Officer, Secretary, Director Joseph W.Kaufmann 59 3/1/1995 1/1/1989
Chief Financial Officer MichaelCelano 53 3/10/2009 3/10/2009
8 additional Officers and Directors records available in full report.

Business Names
Business Name
ILT Acquisition Sub, Inc.
Kensey Nash BVF Technology LLC
Kensey Nash Closure Technology LLC
7 additional Business Names available in full report.

General Information
Number of Employees: 307 (As of 8/31/2011)
Outstanding Shares: 8,669,431 (As of 4/30/2012)
Shareholders: 3,006
Stock Exchange: NASD
Federal Tax Id: 363316412
Fax Number: (484) 713-2900
Email Address: info@kenseynash.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023